Adverse events96

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

41 to 60 of 96

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Seizure	Nervous system disorders	Sarizotan High Dose	0	56
serious	Seizure	Nervous system disorders	Placebo	0	39
serious	Gingival Hypertrophy	Gastrointestinal disorders	Sarizotan Low Dose	1	33	1
serious	Gingival Hypertrophy	Gastrointestinal disorders	Sarizotan High Dose	0	56
serious	Gingival Hypertrophy	Gastrointestinal disorders	Placebo	0	39
serious	Lower respiratory tract infection	Infections and infestations	Sarizotan Low Dose	1	33	1
serious	Lower respiratory tract infection	Infections and infestations	Sarizotan High Dose	1	56	1
serious	Lower respiratory tract infection	Infections and infestations	Placebo	0	39
serious	Gingivitis	Infections and infestations	Sarizotan Low Dose	1	33	1
serious	Gingivitis	Infections and infestations	Sarizotan High Dose	0	56
serious	Gingivitis	Infections and infestations	Placebo	0	39
serious	Medication error	Injury, poisoning and procedural complications	Sarizotan Low Dose	0	33
serious	Medication error	Injury, poisoning and procedural complications	Sarizotan High Dose	1	56	1
serious	Medication error	Injury, poisoning and procedural complications	Placebo	1	39	1
serious	Electrocardiogram QT prolonged	Investigations	Sarizotan Low Dose	0	33
serious	Electrocardiogram QT prolonged	Investigations	Sarizotan High Dose	1	56	1
serious	Electrocardiogram QT prolonged	Investigations	Placebo	1	39	1
serious	Neutropenia	Blood and lymphatic system disorders	Sarizotan Low Dose	0	33
serious	Neutropenia	Blood and lymphatic system disorders	Sarizotan High Dose	1	56	1
serious	Neutropenia	Blood and lymphatic system disorders	Placebo	0	39

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02790034/events?page=3